GSK press releases 中文 关注 Hibsago（贝匹罗韦）在日本获批，成为首个也是唯一一个针对慢性乙型肝炎的功能性治愈疗法” Hibsago首次获得全球批准 Hibsago (bepirovirsen) approved in Japan as first and only functional cure for chronic hepatitis B gsk.com GSK press releases 中文 RSS thenote.app
